228 related articles for article (PubMed ID: 28405138)
1. Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors.
Ballarin R; Cucchetti A; Russo FP; Magistri P; Cescon M; Cillo U; Burra P; Pinna AD; Di Benedetto F
World J Gastroenterol; 2017 Mar; 23(12):2095-2105. PubMed ID: 28405138
[TBL] [Abstract][Full Text] [Related]
2. Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.
Yu S; Yu J; Zhang W; Cheng L; Ye Y; Geng L; Yu Z; Yan S; Wu L; Wang W; Zheng S
J Hepatol; 2014 Oct; 61(4):809-15. PubMed ID: 24824283
[TBL] [Abstract][Full Text] [Related]
3. Viral activity and outcome of hepatitis B surface antigen-positive grafts in deceased liver transplantation.
Lee WC; Chou HS; Lee CS; Wu TH; Wang YC; Cheng CH; Lee CF; Wu TJ; Chan KM
J Viral Hepat; 2018 Jul; 25(7):874-877. PubMed ID: 29431877
[TBL] [Abstract][Full Text] [Related]
4. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
5. Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers.
Tandoi F; Caviglia GP; Pittaluga F; Abate ML; Smedile A; Romagnoli R; Salizzoni M
Dig Liver Dis; 2014 Nov; 46(11):1020-4. PubMed ID: 25201211
[TBL] [Abstract][Full Text] [Related]
6. [A study of the efficacy and safety of using hepatitis B surface antigen-positive donors for liver transplantation].
Ju WQ; He XS; Wang DP; Deng RH; Wu LW; Guo ZY; Zhu XF; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):14-6. PubMed ID: 22464699
[TBL] [Abstract][Full Text] [Related]
7. Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.
Brandl A; Stolzlechner P; Eschertzhuber S; Aigner F; Weiss S; Vogel W; Krannich A; Neururer S; Pratschke J; Graziadei I; Öllinger R
Transpl Int; 2016 Apr; 29(4):471-82. PubMed ID: 26716608
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation from hepatitis B surface antigen-positive donors.
Saidi RF; Jabbour N; Shah SA; Li YF; Bozorgzadeh A
Transplant Proc; 2013; 45(1):279-80. PubMed ID: 23267801
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.
Loggi E; Micco L; Ercolani G; Cucchetti A; Bihl FK; Grazi GL; Gitto S; Bontadini A; Bernardi M; Grossi P; Costa AN; Pinna AD; Brander C; Andreone P
J Hepatol; 2012 Mar; 56(3):579-85. PubMed ID: 22027583
[TBL] [Abstract][Full Text] [Related]
10. Anti-HBc-positive/HBsAg-negative liver donors pose a higher risk of occult HBV infection but do not cause severe histological damage in liver grafts.
Niu Y; Chen X; Feng L; You H; Ren X; Liu H; Zheng J; Shen Z; Jia J
Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):475-80. PubMed ID: 24835492
[TBL] [Abstract][Full Text] [Related]
11. Use and outcomes of hepatitis B virus-positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021.
Ali SE; Vutien P; Bonham CA; Landis C; Kwo P; Esquivel C; Nguyen MH
Liver Transpl; 2023 Jan; 29(1):80-90. PubMed ID: 35844046
[TBL] [Abstract][Full Text] [Related]
12. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.
Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
Transplant Proc; 2012 Sep; 44(7):1960-2. PubMed ID: 22974882
[TBL] [Abstract][Full Text] [Related]
14. Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.
Donataccio D; Roggen F; De Reyck C; Verbaandert C; Bodeus M; Lerut J
Transpl Int; 2006 Jan; 19(1):38-43. PubMed ID: 16359375
[TBL] [Abstract][Full Text] [Related]
15. Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature.
Loggi E; Conti F; Cucchetti A; Ercolani G; Pinna AD; Andreone P
World J Gastroenterol; 2016 Sep; 22(35):8010-6. PubMed ID: 27672295
[TBL] [Abstract][Full Text] [Related]
16. Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience.
Bortoluzzi I; Gambato M; Albertoni L; Mescoli C; Pacenti M; Cusinato R; Germani G; Senzolo M; Rugge M; Boccagni P; Zanus G; Cillo U; Burra P; Russo FP
Transplant Proc; 2013 Sep; 45(7):2707-10. PubMed ID: 24034028
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
18. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.
Vizzini G; Gruttadauria S; Volpes R; D'Antoni A; Pietrosi G; Filì D; Petridis I; Pagano D; Tuzzolino F; Santonocito MM; Gridelli B
Clin Transplant; 2011; 25(1):E77-81. PubMed ID: 21039887
[TBL] [Abstract][Full Text] [Related]
20. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
